The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist

American Journal of Kidney Diseases

Volumn 29, Issue 2, 1997, Pages 254-264

  Zoja, Carla ^a   Donadelli, Roberta ^b   Corna, Daniela ^b   Testa, Davide ^b   Facchinetti, Daniela ^b   Maffi, Raffaello ^b   Luzzana, Elena ^b   Colosio, Vittoria ^b   Bertani, Tullio ^b   Remuzzi, Giuseppe ^b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b NONE

Author keywords

angiotensin II inhibitors; extracellular matrix; Passive Heymann nephritis; transforming growth factor

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MODEL; GLOMERULOSCLEROSIS; HEYMANN NEPHRITIS; HYPERTENSION; INTERSTITIAL NEPHRITIS; MALE; NONHUMAN; PROTEINURIA; RAT;

EID: 12644306869     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90038-X     Document Type: Article

References (45)

1. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
2. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549, 1990
3. Zoja C, Remuzzi A, Corna D, Perico N, Bertani T, Remuzzi G: Renal protective effect of angiotensin-converting enzyme inhibition in aging rats. Am J Med 92:605-635, 1992 (suppl 4B)
4. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
5. Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 2:220-228, 1994
6. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537-543, 1994
7. Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294:1443-1447, 1987
8. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
9. Kamper AL, Straudgaard S, Leyssac PP: Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 5:423-430, 1992
10. Hannedouche T, Landais P, Goldfarb B, El Esper N, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suo JM: Randomized controlled trial of enalapril and β blockers in non-diabetic chronic renal failure. BMJ 309:833-837, 1994
11. Gansevoort RT, de Zeeuw D, de Jong PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 45:861-867, 1994
12. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82:1757-1768, 1988
13. Meyer TW, Anderson S, Rennke HG, Brenner BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31:752-759, 1987
14. Skidgel RA, Schulz WW, Tam LT, Erdos EG: Human renal angiotensin I converting enzyme and neutral endopeptidase. Kidney Int 20:545-546, 1987 (suppl)
15. Mombouli JV, Vanhoutte PM: Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: Role of bradykinin generation during ACE-inhibition. J Cardiovasc Pharmacol 20:S74-S82, 1992 (suppl 9)
16. Hutchison FN, Martin VI: Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome. Am J Physiol 258:F1237-F1244, 1990
17. Hutchison FN, Cui X, Webster SK: The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol 6:1216-1222, 1995
18. Burnier M, Brunner HR: Angiotensin II receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 3:537-545, 1994
19. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB: Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 252:719-725, 1990
20. Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ: In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J Pharmacol Exp Ther 262:139-144, 1992
21. Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ: Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 267:657-663, 1993
22. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
23. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short-and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
24. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925-1930, 1986
25. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 4:19-25, 1996
26. Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A: Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 4:213-221, 1996
27. Feenstra K, van der Lee R, Greben HA, Arends A, Hoedemaeker PJ: Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: A histological and immunohistologic study at the light microscopic and ultrastructural level. Lab Invest 32:235-242, 1975
28. Kerjaschki D, Miettinen A, Farquhar MG: Initial events in the formation of immune deposits in passive Heymann nephritis. J Exp Med 116:109-128, 1987
29. Hutchison FN, Webster SK: Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis. Am J Physiol 263:F311-F318, 1992
30. Ruiz-Ortega M, Gonzalez E, Ortiz A, Egido J: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1791, 1995
31. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
32. Edgington TS, Glassock RJ, Watson JI, Dixon FJ: Characterization and isolation of specific renal tubular epithelial antigens. J Immunol 99:1199-1210, 1967
33. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78:957-962, 1971
34. Read SM, Northcote DH: Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116:53-64, 1981
35. Highashi A, Peters L: A rapid colorimetric method for the determination of inulin in plasma and urine. J Lab Clin Med 35:475-480, 1950
36. Smith HW, Finkelstein N, Aliminosa L, Crawford B: The renal clearance of substituted hippuric acid derivatives and other aromatic acid in dog and man. J Clin Invest 24:388-404, 1945
37. Rambaldi A, Young DC, Griffin ID: Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 69:1409-1413, 1987
38. Feinberg AP, Volgestein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
39. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A: Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76:536-543, 1995
40. Fort P, Marty L, Piechaczyk M, el-Sabrouty S, Dani C, Jeanteur P, Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde 3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442, 1985
41. Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G: Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats. Am J Physiol 267:F1034-F1044, 1994
42. Tolins JP, Raij L: Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 16:452-461, 1990
43. Miller PL, Rennke HG, Meyer TW: Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 261:F459-F465, 1991
44. Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G: Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 7:653-660, 1996
45. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin n stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994